Feasibility of the Overground Bodyweight Supporting Walking System Andago

The overall aim of this project is to investigate the clinical utility of the Andago System, a CE certified mobile bodyweight supporting walking robot, in children with neuromotor disorders. Clinical utility encompasses practicability, acceptability, appropriateness, and accessibility. In this study, the investigators would like to investigate several aspects of clinical utility that belong to the first three components.

Study Overview

• Status: Completed
• Conditions: Stroke; Cerebral Palsy; Traumatic Brain Injury; Gait Disorders, Neurologic; Child, Only; Gait Disorders in Children
• Intervention / Treatment: Device: Andago; Other: Treadmill

Detailed Description

The specific aims of the current project are:

1. To investigate the practicability, the investigators plan to determine the accuracy of the weight-supporting system of the Andago and the time needed for donning and doffing. The investigators also evaluate the number of times that the device stops and the nature of these stops (due to errors, sitting of the patient, when preventing falls, or when the patient moves too fast).
2. To evaluate acceptability, the investigators plan to evaluate differences in motivation and measures reflecting safety (i.e. number of falls prevented) and subjective feeling of safety when patients walk with the Andago compared to walking with their usual walking aids.
3. To evaluate the appropriateness, the investigators are interested in differences between walking on a treadmill and walking overground with this device or changes that occur during walking overground when changing the level of BWS through the unloading system. Therapists should be aware of these differences to know what the advantage of such a system could be or how adjustments in settings influence the walking pattern. The investigators plan two investigations: (a) To determine differences in stride-to-stride variability, leg muscle activation, hip, knee and ankle joint kinematics and other gait parameters during walking in the Andago (overground) versus walking on a treadmill. (b) To determine differences in the same parameters when walking in the Andago with different levels of BWS. These levels are the minimal required level of BWS to walk without buckling the knees (ref BWS), ref BWS plus 15% and ref BWS plus 30%.

To investigate these aims, the patients will be asked to participate in 3 appointments, which should be scheduled within 10 days.

• Study Type: Interventional
• Enrollment (Actual): 20
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Switzerland
  • Zurich
    • Affoltern Am Albis, Zurich, Switzerland, 8910
      • Rehabilitation Center of the University Children's Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: No older than 18 years (ADULT, CHILD)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Neuromotor or orthopaedic disorders
• taller than 135 cm
• able to understand simple instructions
• able to walk 10 meters with or without walking aid
• maximal age of 18 years (a minimal age is not defined as according to the growth curve, children younger than 7-8 years cannot be included because of insufficient height)
• given informed consent.

Exclusion Criteria:

• not consolidated fractures or bone fragility of the lower extremities
• skin lesions in the harness' area which cannot be protected
• unstable hip, knee and/or ankle Joints
• reduced head control or inability to maintain an upright Position
• inability to communicate discomfort or pain
• surgery in the last 3 months
• newly implanted baclofen-pump (or children highly sensitive to it)
• implanted pacemakers
• passive knee extension deficit > 30°
• self-selected walking speed > 3.2 km/h.
• weight > 135 kg
• height > 2 m.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: DEVICE_FEASIBILITY
• Allocation: NON_RANDOMIZED
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Andago; Application of walking over-ground with body-weight support in the Andago	Device: Andago; The Andago is a body-weight supporting device with which a patient can walk overground
ACTIVE_COMPARATOR: Treadmill; Application of walking on a treadmill with body-weight support	Other: Treadmill; Bodyweight supported treadmill walking

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Stride to stride variability	Variability in stride length recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support	Appointment 3 (between minute 25 and minute 55 )

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Leg muscle activity	Amplitude of electromyographic recordings recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support	Appointment 3 (between minute 25 and minute 55 )
Leg joint angles	Joint angles recorded with electrogoniometers during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support	Appointment 3 (between minute 25 and minute 55)

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Bodyweight unloading [kg]	Comparison of bodyweight unloading according to Andago device compared to actual bodyweight unloading measured with scales [kg]	Data are obtained during Appointment 2 (between minute 1 and minute 10)
Number of device stops	Number of Andago device stops measured throughout the habituation periods during appointments 1 and 2	Data are obtained during Appointment 1 between minute 25 and minute 45 and Appointment 2 between minute 10 to 30
Customized questionnaire investigating acceptability [dichotomous]	Participant is being asked whether the patient prefers treadmill or Andago (dichotomous outcome: 0=treadmill/1=Andago), and if the patient would like to train again in the Andago (0=no/1=yes). No sum score is calculated.	At the end of Appointments 1 (between minute 55-58) and the end of Appointment 2 (between minute 40-43)
Questionnaire acceptability [visual analogue scale]	How much fun was it training in the Andago? [score 0=no fun at all to 10=maximal amount of fun]	At the end of Appointments 1 (between minute 59-60) and the end of Appointment 2 (between minute 44-45)
Time needed for donning and doffing [seconds]	Time in seconds needed for mounting the patient in the Andago and, at the end of walking in the Andago, the time needed to get the patient out of the device	During Appointment 1 (mounting around minute 25; taking off around minute 43) and Appointment 2 (mounting around minute 1; taking off around minute 28)
Manual Muscle Testing (MMT)	Manual muscle testing is performed for providing a characterization of the patients. For each muscle group, a score is given between 0 (no visible or palpable contraction) and 5 (patient moves over the full range of motion against gravity with additional maximal resistance). The following muscles will be tested: hip flexors and extensors; hip inner- and outer-rotators; knee flexors and extensors; ankle plantar and dorsal flexors	Appointment 1 between minute 1 and 5
Selective Control Assessment of the Lower Extremity (SCALE)	The SCALE assesses the selectivity of lower extremity joints. It provides a score between 0 (not able) and 2 (normal selectivity) for each of the following joints: hip, knee, ankle, subtalar joint, and toes. It provides a sum score for the left and right leg separately (0= not able; 10= normal selectivity) and an overall sum score (0=not able; 20=normal selectivity)	Appointment 1 between minute 6 and 15 minutes
Active and passive Range of Motion (ROM) of leg joints	Active (by patient) and passive (by therapist) mobility of the hip, knee and ankle joints are made in the sagittal plane. The ROM is noted according to the neutral zero method (degrees). ROM testing is performed for providing a characterization of the patients.	Appointment 1 between minute 16 and 20 minutes
10 meter walk test	Children walk 14 meters; intermediate 10 meters is time stopped to calculate the walking speed	Appointments 1 between minute 21 and 25 and Appointment 3 between minute 1 and 5 and 56 and 60

Collaborators and Investigators

• Sponsor: University Children's Hospital, Zurich
• Collaborators: Mäxi Foundation; Lions Club Zürich-Witikon

Publications and helpful links

General Publications

• van Hedel HJA, Rosselli I, Baumgartner-Ricklin S. Clinical utility of the over-ground bodyweight-supporting walking system Andago in children and youths with gait impairments. J Neuroeng Rehabil. 2021 Feb 8;18(1):29. doi: 10.1186/s12984-021-00827-1.

Study record dates

Study Major Dates

• Study Start (ACTUAL): May 28, 2018
• Primary Completion (ACTUAL): March 19, 2019
• Study Completion (ACTUAL): March 21, 2019

Study Registration Dates

• First Submitted: April 23, 2018
• First Submitted That Met QC Criteria: December 24, 2018
• First Posted (ACTUAL): December 26, 2018

Study Record Updates

• Last Update Posted (ACTUAL): April 18, 2019
• Last Update Submitted That Met QC Criteria: April 17, 2019
• Last Verified: April 1, 2019

More Information

Terms related to this study

• Keywords: Feasibility; Andago; Pediatric Neurorehabilitation
• Additional Relevant MeSH Terms: Pathologic Processes; Brain Diseases; Central Nervous System Diseases; Neurologic Manifestations; Wounds and Injuries; Brain Damage, Chronic; Craniocerebral Trauma; Trauma, Nervous System; Cerebral Palsy; Disease; Brain Injuries; Brain Injuries, Traumatic; Nervous System Diseases; Body Weight; Gait Disorders, Neurologic
• Other Study ID Numbers: 2018-00412

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: We have to check with the local ethics committee whether our pseudonymized data can be shared

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No